NXS next science limited

News: NXS Next Science Says In Talks With Zimmer For Commercialisation, Distribution Rights Of...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    June 24 (Reuters) - Next Science Ltd (NXS) :

    • AGREED FOR TALKS WITH ZIMMER FOR COMMERCIALISATION, DISTRIBUTION RIGHTS TO NEXT SCIENCE'S XPERIENCETM NO RINSE ANTIMICROBIAL SOLUTION
    • ZIMMER INDICATED THAT IT WILL NOT SERVE COMPLAINT ON NEXT SCIENCE, PENDING OUTCOME OF NEGOTIATIONS
    • TALKS FOLLOW COMPLAINT BY ZIMMER IN U.S. COURT OVER COMMERCIAL EXCLUSIVITY RIGHTS OVER XPERIENCETM; CO DENIES ALLEGATIONS
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
14.5¢
Change
0.000(0.00%)
Mkt cap ! $42.43M
Open High Low Value Volume
15.0¢ 15.0¢ 14.5¢ $2.934K 19.70K

Buyers (Bids)

No. Vol. Price($)
11 2572724 14.5¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 582311 7
View Market Depth
Last trade - 16.10pm 09/09/2025 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.